| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/AIHT-2017-68-2998 |
| P698 | PubMed publication ID | 28976882 |
| P50 | author | Aleksandar J Dimovski | Q91153321 |
| P2093 | author name string | Hasime Qorraj Bytyqi | |
| Valon Krasniqi | |||
| Nada Božina | |||
| Livija Šimičević | |||
| Aleksandar Eftimov | |||
| P2860 | cites work | Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 |
| Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics | Q26822796 | ||
| Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review | Q34102026 | ||
| Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia. | Q35549639 | ||
| Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy | Q35603072 | ||
| Frequency of common CYP3A5 gene variants in healthy Polish newborn infants. | Q54455073 | ||
| Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece. | Q54501796 | ||
| Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations | Q57314095 | ||
| Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations | Q35825569 | ||
| PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. | Q35952367 | ||
| Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy. | Q36018001 | ||
| Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy | Q37512208 | ||
| In vitro assessment of the allelic variants of cytochrome P450. | Q37951211 | ||
| Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations. | Q38388873 | ||
| Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations. | Q38616806 | ||
| Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population | Q38802517 | ||
| How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity | Q38811685 | ||
| Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population | Q42284313 | ||
| CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population | Q42315488 | ||
| CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers | Q44432237 | ||
| The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome. | Q45982700 | ||
| Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update | Q46091944 | ||
| Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients. | Q46246088 | ||
| Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. | Q47738894 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | population genetics | Q31151 |
| P304 | page(s) | 180-184 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | Archives of Industrial Hygiene and Toxikology | Q15724434 |
| P1476 | title | Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population | |
| P478 | volume | 68 |
| Q91906258 | Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications | cites work | P2860 |
Search more.